Partners HealthCare and Illumina have entered into agreements with several major laboratories to share interpretation and support services for genetic sequencing. Partners, a Boston-based health care system with nine hospitals in Massachusetts, and Illumina, a San Diego-based manufacturer and distributor of genetic sequencing equipment, have announced a network of laboratories that includes Salt Lake City-based ARUP Laboratories, Mount Sinai Genetic Testing Laboratory, the New York Genome Center, and their own two sites. In a joint statement, Partners and Illumina said the network members are “committed to exploring and sharing knowledge, including variant level content and interpretations, through the formation of inter-laboratory collaborations.” “We’re excited to bring together such a talented and diverse group of leading institutions who share a common vision and are passionate about the opportunities for collaboration to advance the field of clinical genetics,” said Heidi Rehm, the chief laboratory director for Partners’ Laboratory for Molecular Medicine. Last September, Partners and Illumina announced a partnership to create support infrastructure for geneticists and pathologists and networking tools to improve interpretation and reporting. Partners and Illumina intended to fuse their products by installing the Partners-designed software, known as GeneInsight, into MiSeq, Illumina’s gene sequencing hardware. “Today’s announcement represents a significant […]
Partners HealthCare and Illumina have entered into agreements with several major laboratories to share interpretation and support services for genetic sequencing.
Partners, a Boston-based health care system with nine hospitals in Massachusetts, and Illumina, a San Diego-based manufacturer and distributor of genetic sequencing equipment, have announced a network of laboratories that includes Salt Lake City-based ARUP Laboratories, Mount Sinai Genetic Testing Laboratory, the New York Genome Center, and their own two sites.
In a joint statement, Partners and Illumina said the network members are “committed to exploring and sharing knowledge, including variant level content and interpretations, through the formation of inter-laboratory collaborations.”
“We’re excited to bring together such a talented and diverse group of leading institutions who share a common vision and are passionate about the opportunities for collaboration to advance the field of clinical genetics,” said Heidi Rehm, the chief laboratory director for Partners’ Laboratory for Molecular Medicine.
Last September, Partners and Illumina announced a partnership to create support infrastructure for geneticists and pathologists and networking tools to improve interpretation and reporting. Partners and Illumina intended to fuse their products by installing the Partners-designed software, known as GeneInsight, into MiSeq, Illumina’s gene sequencing hardware.
“Today’s announcement represents a significant milestone toward achieving GeneInsight and Illumina’s shared vision of enabling the market to apply sequencing technology to improve human health,” said Matt Posard, an Illumina senior vice president and general manager of Illumina’s translational and consumer business.
The members of the network, known as the GeneInsight Illumina Founding Network, will be used as pilot sites to test the combined software.
“As a user of the GeneInsight application, I look forward to participating in a network of leading genetic testing laboratories and academic institutions to curate genetic variants. This collaborative effort can greatly contribute to improving patient care,” said Elaine Lyon, ARUP’s medical director.
